ACE and chronic kidney disease: Pressure-mediated injury is a well-recognized mechanism for structural damage in CKD.1, 2, 3 Therapies that decrease intraglomerular pressure (angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers) are frequently used for the treatment of CKD and have consistent effects on pathogenic mechanisms related to blood pressure and proteinuria.